Public health issues of hepatitis C virus infection

Area of Science:

• Hepatology
• Virology
• Public Health

Background:

• Hepatitis C virus (HCV) is a major global cause of liver disease, with 130-170 million chronically infected individuals.
• Annual mortality from HCV infection reaches 350,000, with prevalence varying significantly by region.
• Transmission routes include injecting drug use and unsafe therapeutic injections, leading to a large undiagnosed reservoir of chronic infections.

Purpose of the Study:

• To highlight the global burden of Hepatitis C virus infection.
• To discuss the challenges in screening and treatment access.
• To advocate for enhanced public health strategies for HCV management.

Main Methods:

• This study is a review of the global epidemiology and public health implications of Hepatitis C virus.
• Analysis of prevalence, incidence, and transmission patterns of HCV worldwide.
• Examination of barriers to diagnosis and treatment for HCV patients.

Main Results:

• HCV infection affects a substantial portion of the global population, leading to high mortality rates.
• Significant regional disparities exist in HCV prevalence, with higher rates in African and Eastern Mediterranean countries.
• Lack of systematic screening and treatment barriers result in a significant number of undiagnosed and untreated cases.

Conclusions:

• Public health authorities must prioritize Hepatitis C virus, allocating resources for prevention, screening, and management.
• High treatment efficacy necessitates improved access to care to reduce the global burden of HCV.
• Addressing transmission routes and diagnostic/treatment barriers is essential for controlling HCV infection.